Sage Journals: Discover world-class research

Abstract

1 Effect of the diphenyl ether herbicide fomesafen on liver preneoplastic changes and porphyrin biosynthesis was examined in male C57BL/6J mice (0.23% in the diet for 14 months) and ICR mice (0.3% in the diet for 50 weeks). Fomesafen treatment resulted in preneoplastic changes (liver nodules and foci of altered hepatocytes) in both strains, uroporphyria developed only in ICR mice.

2 Iron pretreatment (600 mg/kg as a single dose) accelerated the development of fomesafen-induced preneoplastic changes in both mouse strains. The number of foci containing altered hepatocytes, as well as the number and size of liver nodules, were increased in iron-pretreated animals.

3 A single injection of iron induced marked uroporphyria in C57BL/6J mice after 14 months (liver porphyrin content 102 nmol/g). This uroporphyria was further potentiated by fomesafen administration (208 nmol/g).

4 In ICR mice, liver histology was apparently normal after a 3 month recovery from fomesafen treatment (0.32% for 9 months). Liver porphyrin content (260 nmol/g) started to decrease immediately after fomesafen withdrawal, but was still significantly elevated after 3 months (5 nmol/g), as compared to controls (1 nmol/g).

5 It is concluded that the toxicological evaluation of fomesafen should focus on liver porphyrin biosynthesis.

Keywords

fomesafen herbicides liver neoplasms peroxisome proliferation porphyria uroporphyrins

References

Matringe M , Camadro JM , Labbe P , Scalla R . Protoporphyrinogen oxidase inhibition by three peroxidizing herbicides: Oxadiazon, LS-82-556 and M&B 39279 . FEBS Letters 1989; 245: 35–38 .

Witkowski DA , Halling BP Inhibition of plant protoporphyrinogen oxidase by the herbicide acifluorfen methyl . Plant Physiology 1989; 90: 1239–1242 .

Butler EG et al. Induction of hepatic peroxisome proliferation in mice by lactofen, a diphenyl ether herbicide . Toxicology and Applied Pharmacology 1988; 93: 72-80 .

Smith LL , Elcombe CR . Mechanistic studies: their role in the toxicological evaluation of pesticides . Food Additives and Contaminants 1989; 6 (Suppl 1) S57–S65 .

AshbyJ et al. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis . Human and Experimental Toxicology 1994; 13 (Suppl 2) S1–S117 .

QuestJA et al. Evaluation of the carcinogenic potential of pesticides 1. Acifluorfen . Regulatory Toxicology and Pharmacology 1989; 10: 149–159 .

Blaauboer BJ et al. The effect of beclobric acid and clofibric acid on perixosomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes . Biochemical Pharmacology 1990; 40: 521–528 .

Perrone CE , Shao L , Williams GM . Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes . Toxicology and Applied Pharmacology 1998; 150: 277–286 .

KrijtJ et al. Herbicide-induced experimental variegate porphyria in mice: tissue porphyrinogen accumulation and response to porphyrogenic drugs . Canadian Journal of Physiology and Pharmacology 1997; 75: 1181–1187 .

10.

Krijt J et al. Effect of the protoporphyrinogen, oxidase-inhibiting herbicide fomesafen on liver uroporphyrin and heptacarboxylic porphyrin in two mouse strains . Food and Chemical Toxicology 1994; 32: 641–650 .

11.

De Matteis F . Drug-induced abnormalities of liver heme biosynthesis. In: Meeks RG , Harrison SD , Bull RJ (eds.) Hepatotoxicology. CRC Press, Boca Raton , 1991, pp 437–478.

12.

De Matteis F . Porphyria cutanea tarda of the toxic and sporadid varieties . Clinics in Dermatology 1998; 16: 265–275 .

13.

Smith AG , Francis JE . Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice . Biochemical Journal 1983; 214: 909–913 .

14.

Smith AG et al. Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL/10ScSn mice . International Journal of Cancer 1989; 43: 492–496 .

15.

Smith AG et al. Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene . Carcinogenesis 1993; 14: 1381–1387 .

16.

Smith AG et al. Synergy of iron in the toxicology and carcinogenicity of polychlorinated biphenyls (PCBs) and related chemicals . Toxicology Letters 1995; 82/83: 945–950 .

17.

Koss G et al. 2,2′,3′,4,4′,5,5′ Heptachlorobiphenyl (PCB 180) on its toxicokinetics, biotransformation and porphyrinogenic action in female rats . Archives of Toxicology 1993; 67: 651–654 .

18.

Fakan F et al. Liver cell cytoplasmic inclusions in experimental porphyrias: Their demonstration with the ferricyanide reduction reaction . Experimental and Toxicologic Pathology 1997; 49: 289–293 .

19.

Rutten AAJJL et al. Interlaboratory comparison of microsomal ethoxyresorufin and pentoxyresorufin O-dealkylation determinations: standardization of assay conditions . Archives of Toxicology 1992; 66: 237–244 .

20.

Lazarow PB . Assay of peroxisomal beta oxidation of fatty acids. In: Lowenstein JM (ed.). Methods in Enzymology, vol 72. Academic Press, NY , pp 315–319.

21.

Brumby PE , Massey V . Determination of nonheme iron, total iron, and copper. In: Eastabrook RW , Pullman ME (eds.) Methods in Enzymology, vol 10. Academic Press, NY , pp. 463–474.

22.

Smith A , Francis JE . Genetic variation of iron induced uroporphyria in mice . Biochemical Journal 1993; 291: 29–35 .

23.

Sinclair PR et al. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(7/7) null mutant mice . Biochemical Journal 1998; 330: 149–153 .

24.

Bock KW et al. Persistently increased expression of a 3-methylcholanthrene inducible phenol uridine diphosphate glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas . Cancer Research 1990; 50: 3569–3573 .

25.

Williams GM , Yamamoto RS . Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis . Journal of the National Cancer Institute 1972; 49: 685–692 .

26.

Salata H et al. Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors . Journal of Hepatology 1985; 1: 477–474 .

27.

Kauppinen R , Mustajoki P . Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases . Medicine 1992; 71: 1-13 .

28.

Andant C , Puy H , Faivre J , Deybach JC . Acute hepatic porphyrias and primary liver cancer . New England Journal of Medicine 1998; 338: 1853–1854 .

29.

Youssef J , Badr M . Extraperoxisomal targets of peroxisome proliferators: Mitochondrial, microsomal and cytosolic effects. Implications for health and disease . Critical Reviews in Toxicology 1998; 28: 1–33 .

30.

Cripps DJ , Peters HA , Gocmen A , Dogramici I . Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients . British Journal of Dermatology 1984; 111: 413–422 .

31.

Koss G et al. Studies on the toxicology of hexachlorobenzene. V. Different phases of porphyria during and after treatment . Archives of Toxicology 1983; 52: 13–22 .

32.

Birchfield NB , Casida JE . Protoporphyrinogen oxidase: high affinity tetrahydrophthalimide radioligand for the inhibitor/herbicide-binding site in mouse liver mitochondria . Chemical Research in Toxicology 1996; 9: 1135–1139 .

Liver preneoplastic changes in mice treated with the herbicide fomesafen

Abstract

Keywords

References